A comparison of the quality of life of patients with metastatic prostate cancer who received or did not receive hormonal therapy
- PMID: 8428337
- DOI: 10.1002/1097-0142(19930201)71:3+<1143::aid-cncr2820711437>3.0.co;2-i
A comparison of the quality of life of patients with metastatic prostate cancer who received or did not receive hormonal therapy
Abstract
Background and methods: The quality of life in patients who elected to receive hormonal therapy for newly diagnosed asymptomatic metastatic prostate cancer was compared with a comparable group of patients who chose to defer immediate intervention.
Results and conclusions: The premise that active therapy, despite its side effects, would improve or maintain the psychosocial quality of life was not substantiated, and the no-therapy group had better physical and sexual functioning.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical